SiftMed
Develops AI software that surfaces relevant facts from large volumes of medical records for healthcare-adjacent workflows.
Overview
SiftMed builds AI technology for reviewing large volumes of medical records, helping users identify relevant facts that may be missed in manual review. Its product is positioned for organizations that need to process complex clinical documentation at scale. The company’s differentiation centers on applying AI to medical-record analysis, where speed and accuracy can be constrained by the volume and complexity of files. SiftMed has raised $5 million in an undisclosed round announced in July 2026, representing its total disclosed funding to date.
Funding History
SiftMed lands $5 million to find the facts humans can miss in mountains of medical records
Frequently Asked Questions
- How much has SiftMed raised in total?
- SiftMed has raised a total of $5M across 1 funding round.
- Who are SiftMed's investors?
- SiftMed's investors include Toronto’s Staircase Ventures.
- What does SiftMed do?
- SiftMed builds AI technology for reviewing large volumes of medical records, helping users identify relevant facts that may be missed in manual review. Its product is positioned for organizations that need to process complex clinical documentation at scale. The company’s differentiation centers on applying AI to medical-record analysis, where speed and accuracy can be constrained by the volume and complexity of files. SiftMed has raised $5 million in an undisclosed round announced in July 2026, representing its total disclosed funding to date.
- Where is SiftMed headquartered?
- SiftMed is headquartered in St. John's, Canada.
Related Insights
A comprehensive analysis of Sage's funding history, investors, competitive position, and growth trajectory in the AI Healthcare space.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $35.9 billion raised across 95 deals, with 15 mega-rounds capturing 85.5% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.